MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
Panpan Hao(Ningxia Medical University), Qimou Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Huaying An(Qilu Hospital of Shandong University), Cong Fan(Qilu Hospital of Shandong University), Qianqian Wang(Qingdao University), Yun Zhang(Baylor College of Medicine), Xiaolin Liu(The Fifth People’s Hospital of Suzhou), Mei Zhang(Shandong University), Cheng Zhang(Shanghai Sixth People's Hospital), Lijun Fang(Qilu Hospital of Shandong University), Lina Yao(Shandong University), Dongdong Liu(Qilu Hospital of Shandong University)
Cited by 16
Related Papers
Traditional Chinese Medicine for Cardiovascular Disease
|Journal of the American College of Cardiology|2017|592
Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
|Experimental & Molecular Medicine|2019|337
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
|Cardiovascular Research|2021|270
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|248